Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Fuji
Dow
US Department of Justice
AstraZeneca
McKinsey
Cantor Fitzgerald
Colorcon
Chinese Patent Office

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,460,704

« Back to Dashboard

Which drugs does patent 8,460,704 protect, and when does it expire?


Patent 8,460,704 protects VIRAMUNE XR and is included in one NDA. There has been one Paragraph IV challenge on Viramune XR.

This patent has thirty patent family members in twenty-seven countries.

Summary for Patent: 8,460,704

Title:Extended release formulation of nevirapine
Abstract: The invention relates to an extended release pharmaceutical composition comprising nevirapine.
Inventor(s): Cappola; Michael L. (Malvern, PA), Sienkiewicz; Svetlana (New Milford, CT), Snow; Glenn Charles (Sandy Hook, CT), Chen; Feng-Jing (Danbury, CT)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:12/523,226
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Boehringer Ingelheim
VIRAMUNE XR
nevirapine
TABLET, EXTENDED RELEASE;ORAL201152-001Mar 25, 2011ABRXYesYes► Subscribe► Subscribe TREATMENT OF HIV-1 BY ONCE DAILY ADMINISTRATION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,460,704

PCT Information
PCT FiledJune 04, 2008PCT Application Number:PCT/US2008/065705
PCT Publication Date:December 18, 2008PCT Publication Number: WO2008/154234

International Patent Family for Patent: 8,460,704

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Tunisia2009000510► Subscribe
Poland2155169► Subscribe
Peru10352013► Subscribe
Peru03712009► Subscribe
New Zealand578664► Subscribe
Mexico2009007764► Subscribe
Morocco31430► Subscribe
South Korea101017862► Subscribe
South Korea20100020447► Subscribe
Japan5417662► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
QuintilesIMS
Medtronic
Cerilliant
Cantor Fitzgerald
Covington
Federal Trade Commission
Chinese Patent Office
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot